Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128) |
---|
11/21/2002 | US20020173498 Topical administering; skin disorders |
11/21/2002 | US20020173497 Stability; oral administering; anticancer agents |
11/21/2002 | US20020173496 Formulation containing novel anti-inflammatory androstane derivative |
11/21/2002 | US20020173487 Cyclodextrin-drospirenone inclusion complexes |
11/21/2002 | US20020173485 Mixture of hyaluronic acid and polyvinylpyrrolidone |
11/21/2002 | US20020173474 Methods & materials involving dimerization-mediated regulation of biological events |
11/21/2002 | US20020173472 Pharmaceutical formulations of resveratrol |
11/21/2002 | US20020173467 Peptide in biopolymer; oil in water emulsion |
11/21/2002 | US20020173456 Complex of macromolecules and peptide; supplying cells |
11/21/2002 | US20020173451 Using mixture of prostate specific antigen and radiation therapy |
11/21/2002 | US20020172942 Composition for use in the treatment and prevention of viral infections |
11/21/2002 | US20020172933 Protected during pasteurization stabilizers (monosaccharides, disaccharides, and oligosaccharides; or amino acids) |
11/21/2002 | US20020172727 Multiparticulate formulations of lithium salts for oral administration suitable for once-a-day administration |
11/21/2002 | US20020172721 Vitamin formulation for cardiovascular health |
11/21/2002 | US20020172712 Antiemetic, anti-motion sustained release drug delivery system |
11/21/2002 | US20020172680 Diagnosis of metastatic cancer by the mts-1 gene |
11/21/2002 | US20020172670 Used to generate models for elucidating the structure of other polypeptides and for better identifying ligands capable of modulating mannosidase II activity |
11/21/2002 | US20020172661 For diagnosis, prevention, or treatment of diseases responsive to therapy with interferon- beta (IFN-beata) |
11/21/2002 | US20020172649 Pharmaceutical composition |
11/21/2002 | CA2826627A1 Specific binding proteins and uses thereof |
11/21/2002 | CA2778114A1 Abuse-resistant opioid dosage form |
11/21/2002 | CA2448195A1 Minoxidil-containing liquid composition |
11/21/2002 | CA2447574A1 Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
11/21/2002 | CA2447548A1 Complexes for transferring substances of interest into a cell |
11/21/2002 | CA2447444A1 Antisense permeation enhancers |
11/21/2002 | CA2447395A1 Targeted delivery of drugs for the treatment of parasitic infections |
11/21/2002 | CA2447287A1 Immunoconjugates made of egg-yolk antibodies (igy), production and use thereof in diagnoses and therapy |
11/21/2002 | CA2447275A1 Therapeutic delivery of carbon monoxide |
11/21/2002 | CA2447005A1 Oral controlled release pharmaceutical composition for one-a-day therapy for the treatment and prophylaxis of cardiac and circulatory diseases |
11/21/2002 | CA2446957A1 Compaction process for manufacture of sodium phenytoin dosage form |
11/21/2002 | CA2446751A1 Kavalactone compositions and methods of use |
11/21/2002 | CA2446589A1 Methods for treating cancer |
11/21/2002 | CA2446555A1 Immunogenic conjugates of low molecular weight hyaluronic acid with polypeptide toxins |
11/21/2002 | CA2446106A1 System for delivering cosmetics and pharmaceuticals |
11/21/2002 | CA2445606A1 Taste masking pharmaceutical composition |
11/20/2002 | WO2001091755A1 Active substance combination containing a compound with an opioid effect and at least one further compound of formula i |
11/20/2002 | WO2001090252A1 Gelling composition |
11/20/2002 | EP1258775A2 Photothermographic materials and recording processes therefor |
11/20/2002 | EP1258522A2 A method of controlling the oxidation of chemicals during storage using noble gases |
11/20/2002 | EP1258497A2 Conjugates of factor VIII and a biocompatible polymer |
11/20/2002 | EP1258255A1 Conjugates of an antibody to CD44 and a maytansinoid |
11/20/2002 | EP1258249A1 Oral preparations for diabetes |
11/20/2002 | EP1258246A2 Controlled release oxycodone compositions |
11/20/2002 | EP1258245A2 Accelerated release composition containing bromocriptine |
11/20/2002 | EP1258241A1 Method of increasing the bioavailability of nimesulide |
11/20/2002 | EP1258200A2 Use of hydroxyflavones for masking of bitterness, and food and pharmaceutical compositions comprising an effective amount thereof |
11/20/2002 | EP1257827A1 Diagnosis of breast cancer using bcmp-11 as marker |
11/20/2002 | EP1257695A1 Biomolecules having multiple attachment moieties for binding to a substrate surface |
11/20/2002 | EP1257654A1 M cell directed vaccines |
11/20/2002 | EP1257574A1 Improved interleukin 10 |
11/20/2002 | EP1257304A1 Foam-forming wound dressing |
11/20/2002 | EP1257299A2 Radioactive therapeutic liposomes |
11/20/2002 | EP1257297A2 Compositions and methods for treatment of angiogenesis in pathological lesions |
11/20/2002 | EP1257296A2 Caspase activated prodrugs therapy |
11/20/2002 | EP1257295A2 Factor vii or viia-like molecules |
11/20/2002 | EP1257291A1 Novel antibody with specificity for colon cancer |
11/20/2002 | EP1257285A2 Use of breast cancer associated membrane proteins (bcmp) for treatment, prophylaxis and diagnosis of breast cancer |
11/20/2002 | EP1257269A1 Orally administrable acid stable anti-ulcer benzimidazole derivatives |
11/20/2002 | EP1257259A1 Controlled release ceramic particles, compositions thereof, processes of preparation and methods of use |
11/20/2002 | EP1257257A2 Delivery systems using preformed biodegradable polymer compositions and methods |
11/20/2002 | EP1257248A1 Pharmaceutical composition |
11/20/2002 | EP1107732B1 Oral liquid mucoadhesive compositions |
11/20/2002 | EP1054666B1 Liquid pharmaceutical formulation containing zotepine |
11/20/2002 | EP1052995B1 Pharmaceutical composition for nasal administration of thiocolchicoside |
11/20/2002 | EP1003525B1 Composition and method for regulating cell proliferation and cell death |
11/20/2002 | EP0954337B1 Intestinal absorption of nicotine to treat nicotine responsive conditions |
11/20/2002 | EP0929314B1 Pharmaceutical formulations of corticotropin releasing factor having improved stability in liquid form |
11/20/2002 | EP0879050B1 Captopril tablets |
11/20/2002 | EP0868174B1 Oral gel capsule formulation of 1,2,4-benzotriazine oxides |
11/20/2002 | EP0847280B1 Compositions and their uses against hyperacute rejection of xenografts and certain diseases |
11/20/2002 | EP0711127B1 Methods of preparing gas-filled liposomes |
11/20/2002 | EP0695169B1 Multivesicular cyclodextrin liposomes encapsulating pharmacologic compounds and methods for their use |
11/20/2002 | EP0681481B1 Highly soluble multicomponent inclusion complexes containing a base type drug, an acid and a cyclodextrin |
11/20/2002 | CN1380830A Patch containing 4-biphenylacetic acid |
11/20/2002 | CN1380829A Rapidly disintegrating table and process for manufacture thereof |
11/20/2002 | CN1380064A Method for producing antibiotic preparation and its application |
11/20/2002 | CN1094361C Composition comprising propolis and essential oil |
11/20/2002 | CN1094351C External-use medicine 'Gujiasan' powder and its preparing method |
11/20/2002 | CN1094350C Preparation for epidermis and process for its preparation |
11/20/2002 | CN1094349C Pharmaceutical composition |
11/20/2002 | CN1094326C Carotenoid preparation having mixture of beta-carotene, ycopene and xanthophyll |
11/20/2002 | CA2410038A1 Gelling composition |
11/19/2002 | US6482987 Pharmaceutical composition containing bupropion hydrochloride and a stabilizer |
11/19/2002 | US6482943 Quinones as disease therapies |
11/19/2002 | US6482917 Method for producing powder-shaped cross-linked polymerizates |
11/19/2002 | US6482823 Taste masked pharmaceutical liquid formulations |
11/19/2002 | US6482811 Bretylium compositions and kits, and their use in preventing and treating cardio-vascular conditions |
11/19/2002 | US6482586 Hybrid compositions for intracellular targeting |
11/19/2002 | US6482518 Excipient for the lyophilization of aqueous suspensions of microparticles |
11/19/2002 | US6482517 Coated particles, methods of making and using |
11/19/2002 | US6482439 Drug delivery system exhibiting permeability control |
11/19/2002 | US6482438 Apparatus and process for preparing crystalline particles |
11/19/2002 | US6482437 Morphine sulfate microgranules, manufacturing process and pharmaceutical preparations |
11/19/2002 | US6482435 Temperature sensitive gel for sustained delivery of protein drugs |
11/19/2002 | US6482433 Instant foods, beverages |
11/19/2002 | US6482431 Method for application and maintenance of medication on body tissue |
11/19/2002 | US6482430 Improvements Relating To Bran Gels |
11/19/2002 | US6482429 Stable powder inhalation dosage formulation |
11/19/2002 | US6482426 Compositions for the treatment of male erectile dysfunction |
11/19/2002 | US6482421 Pharmaceuticals, dietary supplements and cosmetic compositions, and the use of certain mixtures for preparing a medicament or a dietary supplement for the treatment or prevention of inflammation, hypersensitivity reactions or pain |